癌症进展2024,Vol.22Issue(15) :1723-1726,1735.DOI:10.11877/j.issn.1672-1535.2024.22.15.25

鼠类肉瘤病毒癌基因同源物B、大鼠肉瘤癌基因在甲状腺癌中的表达及甲状腺癌患者治疗效果的影响因素分析

Expression of v-raf murine sarcoma viral oncogene homolog B and rat sarcoma oncogene in thyroid cancer and analysis of influencing factors of treatment efficacy in thyroid cancer patients

邢丽培 黄丽贞 田冬明 寇小兵
癌症进展2024,Vol.22Issue(15) :1723-1726,1735.DOI:10.11877/j.issn.1672-1535.2024.22.15.25

鼠类肉瘤病毒癌基因同源物B、大鼠肉瘤癌基因在甲状腺癌中的表达及甲状腺癌患者治疗效果的影响因素分析

Expression of v-raf murine sarcoma viral oncogene homolog B and rat sarcoma oncogene in thyroid cancer and analysis of influencing factors of treatment efficacy in thyroid cancer patients

邢丽培 1黄丽贞 2田冬明 3寇小兵1
扫码查看

作者信息

  • 1. 许昌市中心医院 内分泌科,河南 许昌 461000
  • 2. 许昌市人民医院药学部,河南 许昌 4610000
  • 3. 许昌市中心医院 甲状腺外科,河南 许昌 461000
  • 折叠

摘要

目的 探讨鼠类肉瘤病毒癌基因同源物B(BRAF)、大鼠肉瘤癌基因(RAS)在甲状腺癌中的表达及甲状腺癌患者治疗效果的影响因素.方法 选取78例甲状腺癌患者作为观察组,61例甲状腺良性肿瘤患者作为对照组,采用免疫组化法检测两组患者肿瘤组织中BRAF、RAS表达情况,比较两组患者及不同临床特征甲状腺癌患者BRAF、RAS阳性表达情况.根据治疗效果将甲状腺癌手术患者分为治疗成功和治疗不成功,采用Logis-tic回归模型分析甲状腺癌患者治疗效果的影响因素.结果 观察组患者BRAF、RAS阳性表达率均明显高于对照组,差异均有统计学意义(P﹤0.01).不同肿瘤家族史甲状腺癌患者BRAF阳性表达情况比较,差异有统计学意义(P﹤0.05).不同TNM分期、淋巴结转移情况甲状腺癌患者RAS阳性表达情况比较,差异均有统计学意义(P﹤0.05).78例甲状腺癌患者中,治疗成功48例,治疗不成功30例,治疗成功与治疗不成功甲状腺癌患者促甲状腺激素水平、甲状腺球蛋白水平、BRAF表达情况、RAS表达情况比较,差异均有统计学意义(P﹤0.05).多因素Logistic回归分析结果显示,RAS表达情况、促甲状腺激素水平、甲状腺球蛋白水平均是甲状腺癌患者治疗效果的独立影响因素(P﹤0.05).结论 BRAF、RAS在甲状腺癌患者中的阳性表达率较高,并且BRAF阳性表达与肿瘤家族史有关,RAS阳性表达与TNM分期、淋巴结转移情况有关.RAS表达情况、促甲状腺激素水平、甲状腺球蛋白水平均是甲状腺癌患者治疗效果的独立影响因素.

Abstract

Objective To investigate the expression of v-raf murine sarcoma viral oncogene homolog B(BRAF)and rat sarcoma oncogene(RAS)in thyroid cancer and the influencing factors of treatment efficacy in thyroid cancer patients.Method A totol of 78 patients with thyroid cancer were selected as the observation group and 61 patients with thyroid benign tumor were selected as the control group.The expressions of BRAF and RAS in tumor tissues of the two groups were detected by immunohistochemistry,and the positive expressions of BRAF and RAS of the two groups and thyroid cancer patients with different clinical characteristics were compared.According to the treatment efficacy,thyroid cancer surgery patients were divided into successful treated and unsuccessful treated,and Logistic regression model was used to analyze the influencing factors of treatment efficacy in thyroid cancer patients.Result The positive expression rates of BRAF and RAS in observation group were significantly higher than those in control group,and the differences were sta-tistically significant(P<0.01).There was significant difference in BRAF positive expression in thyroid cancer patients with different family histories(P<0.05).There were significant differences in RAS positive expression in thyroid cancer patients with different TNM stages and lymph node metastasis(P<0.05).Among 78 patients with thyroid cancer,48 were successful treated and 30 were unsuccessful treated.There were statistically significant differences in the levels of thyro-tropin,thyroglobulin,BRAF expression and RAS expression between successful treated and unsuccessful treated patients(P<0.05).Logistic regression analysis showed that RAS expression,thyrotropin level and thyroglobulin level were inde-pendent influencing factors on the treatment efficacy of thyroid cancer patients(P<0.05).Conclusion The positive ex-pression rates of BRAF and RAS in thyroid cancer patients are high,and the positive expression of BRAF is related to the family history of the tumor,and the positive expression of RAS is related to the TNM stage and lymph node metastasis.RAS expression,thyrotropin level and thyroglobulin level were independent influencing factors on the treatment efficacy of thyroid cancer patients.

关键词

鼠类肉瘤病毒癌基因同源物B/大鼠肉瘤癌基因/甲状腺癌/治疗效果/影响因素

Key words

v-raf murine sarcoma viral oncogene homolog B/rat sarcoma oncogene/thyroid cancer/treatment effica-cy/influencing factor

引用本文复制引用

出版年

2024
癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
段落导航相关论文